Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies-Reference-Cited by-同舟云学术

Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies

Published:2019-04-23 Issue:6 Volume:28 Page:854-859
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Noble Carl W.¹^ORCID,Gangaputra Sapna S.²^ORCID,Thompson Ian A.³,Yuan Amy⁴^ORCID,Apolo Andrea B.⁵^ORCID,Lee Jung-Min⁵,Papaliodis George N.⁴,Kodati Shilpa³,Bishop Rachel³,Magone M. Teresa⁶^ORCID,Sobrin Lucia⁴^ORCID,Sen H. Nida³^ORCID

Affiliation:

1. Department of Ophthalmology, George Washington University, Washington DC, USA

2. Department of Ophthalmology, Vanderbilt Eye Institute, Nashville, USA

3. Department of Ophthalmology, National Eye Institute, Bethesda, USA

4. Department of Ophthalmology, Massachusetts Eye and Ear Institute, Boston, USA

5. Department of Oncology, National Cancer Institute, Bethesda, USA

6. Department of Ophthalmology, Washington DC Veterans Hospital, Washington DC, USA

Funder

NEI intramural research program

Publisher

Informa UK Limited

Subject